{
    "2019-08-19": [
        [
            {
                "time": "",
                "original_text": "机会来了？43只医药股获股东增持 4大细分领域受青睐",
                "features": {
                    "keywords": [
                        "医药股",
                        "股东增持",
                        "细分领域",
                        "青睐"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "格隆汇个股放量排行榜 | 8月19日",
                "features": {
                    "keywords": [
                        "个股",
                        "放量",
                        "排行榜"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "罗氏再遭重击！UNH将安进两款生物仿制药列为目录首选药物",
                "features": {
                    "keywords": [
                        "罗氏",
                        "重击",
                        "UNH",
                        "安进",
                        "生物仿制药",
                        "目录首选"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "“4+7”扩面跨国、本土药企心态大不同？",
                "features": {
                    "keywords": [
                        "4+7",
                        "扩面",
                        "跨国药企",
                        "本土药企",
                        "心态"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "西安国际医学中心开诊在即 国际医学新增医疗供给有望进入收获期",
                "features": {
                    "keywords": [
                        "西安国际医学中心",
                        "开诊",
                        "医疗供给",
                        "收获期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}